Redwire Space– tag –
-
Redwire Completes ISS On-Orbit Operations for Cancer Therapeutic Candidate Rebecsinib and Pharmaceutical Crystal Growth Studies with Multiple Partners
Redwire (Press Release) USA Overview Redwire completed on-orbit operations for a new batch of pharmaceutical drug development investigations aboard the International Space Station (ISS), with samples returning to Earth on June 17, 2026. ... -
Private Firms Step Up Microgravity Drug R&D and Develop Commercial Space Stations as ISS Deorbit Nears
PharmaVoice USA Overview As the International Space Station (ISS) approaches deorbit, private companies are taking the lead to continue microgravity drug research and development (R&D). Despite the proven success of over a decade of ... -
ISS National Lab Drives Breakthroughs in Disease Modeling, Regenerative Medicine, and Materials Production Through Microgravity Research
ISS National Lab USA Overview The International Space Station (ISS) National Lab is propelling significant advancements in diverse fields such as disease modeling, tissue engineering, therapeutic development, and materials production thr...
